MIC-B12 Shots: Access & Clinical Considerations

Last reviewed: May 31, 2026

Last updated: May 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

MIC-B12 shots deliver methionine, inositol, choline, and cyanocobalamin via intramuscular injection for metabolic and energy support. Safe access requires baseline lab screening including homocysteine, methylmalonic acid, and complete metabolic panels to assess B12 status and metabolic function.

Obtaining MIC-B12 shots involves navigating telehealth providers, licensed compounding pharmacies, and clinical eligibility criteria. PlexusDx supports precision-wellness decisions by helping patients understand biomarker context and genetic predispositions that inform whether B12 supplementation aligns with individual metabolic profiles.

Understanding MIC-B12 and Metabolic Indicators

MIC-B12 contains three lipotropic compounds—methionine, inositol, and choline—plus B12. These amino acids and nutrients support liver function, fat metabolism, and energy production. Clinical value depends on baseline B12 status, homocysteine levels, and metabolic rate.

B12 deficiency impairs methylation cycles and mitochondrial energy synthesis. Screening via serum B12, holotranscobalamin, and methylmalonic acid identifies actual deficiency versus subclinical insufficiency. This distinction guides whether MIC-B12 therapy addresses a clinical need or represents optimization.

Access Routes: Telehealth Providers and Compounding Pharmacies

Licensed telehealth providers evaluate candidacy for MIC-B12 through medical history, symptom review, and lab orders. Qualified practitioners order baseline labs, assess drug interactions, and verify methylation and metabolic markers before authorizing injections.

Access Method	Key Characteristics
Telehealth practitioners	Remote medical evaluation, lab ordering, ongoing monitoring required
Licensed 503A compounding pharmacies	Require valid provider prescription; formulate custom doses safely
Direct-to-consumer programs	May lack baseline screening; higher risk without medical oversight
In-office wellness clinics	Provide B12 injections same-day; require in-person evaluation first

Biomarker Screening Before Starting MIC-B12 Therapy

Pre-treatment labs should include serum B12, folate, methylmalonic acid, homocysteine, complete blood count, and comprehensive metabolic panel. These markers reveal whether B12 deficiency, metabolic dysfunction, or nutrient malabsorption exists and whether MIC-B12 directly addresses the underlying issue.

Elevated homocysteine or methylmalonic acid despite normal serum B12 suggests functional B12 insufficiency. Genetic variations in methionine synthase (MTHFR) and cobalamin metabolism genes can predispose individuals to poor B12 utilization, making biomarker context clinically essential before therapy initiation.

Safety Considerations and Medical Provider Guidance

MIC-B12 injections carry low risk when prescribed by qualified providers and administered via licensed pharmacies. Contraindications include pernicious anemia without intrinsic factor replacement, untreated folate deficiency, and certain cardiac conditions. Providers assess medication interactions and renal/hepatic function before authorization.

Compounding pharmacies must follow 503A regulations, including sterility testing, pharmaceutical grade ingredients, and patient safety protocols. Telehealth providers should order follow-up labs 4–8 weeks post-initiation to measure metabolic response and adjust dosing. Medical oversight ensures injections deliver clinical benefit rather than represent unmonitored supplementation.

How PlexusDx Supports a More Personalized Approach

PlexusDx Precision Peptide Genetic Test reveals predispositions in metabolic and methylation pathways—including MTHFR, COMT, and methionine synthase variants—that may help provide context for B12 utilization and lipotropic compound metabolism. Genetic markers can inform whether MIC-B12 directly addresses an individual's metabolic profile.

The genetic test identifies genetic predispositions related to nutrient absorption and methylation capacity, which should be interpreted with a qualified healthcare provider. Results do not predict exact B12 response or metabolic outcomes; they support a more informed conversation about whether MIC-B12 therapy aligns with your unique biochemistry.

Understanding your genetic and biomarker context enables providers to make evidence-based decisions about MIC-B12 candidacy, dosing, and monitoring frequency. This precision-wellness approach reduces trial-and-error supplementation and prioritizes metabolic testing alongside genetic insights for optimal safety and efficacy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Do I need a prescription to obtain MIC-B12 shots?

Yes. MIC-B12 is a prescription medication requiring evaluation by a licensed provider and filling through a licensed compounding pharmacy. Telehealth practitioners can issue prescriptions after medical assessment and lab review.

What baseline labs should I have before starting MIC-B12?

Essential labs include serum B12, folate, methylmalonic acid, homocysteine, CBC, and comprehensive metabolic panel. These assess B12 status, methylation capacity, and metabolic health to confirm MIC-B12 is clinically appropriate.

How much do MIC-B12 shots cost through PlexusDx partners?

Pricing varies by 503A compounding pharmacy and dosage. Typical costs range $40–$80 per injection. PlexusDx works with licensed compounders to ensure transparent, regulated pricing and quality assurance.

Are there side effects or contraindications with MIC-B12?

Most people tolerate MIC-B12 well. Rare side effects include injection site reaction, hyperuricemia, or allergic response. Contraindications include pernicious anemia without intrinsic factor support and untreated folate deficiency. Providers screen for these before authorization.

How does my genetic profile relate to MIC-B12 efficacy?

Variants in MTHFR, COMT, and methionine synthase genes affect B12 metabolism and methylation capacity. PlexusDx Precision Peptide Genetic Test may help provide context for your metabolic predispositions; results should be discussed with your provider to guide personalized MIC-B12 dosing and monitoring.

Where To Get MIC-B12 Shots: Biomarker Context and Provider Guidance